Nebulization solutions contaminated with microorganisms can be sources of infection.
MATERIALS AND METHODS

Microbial Contamination of Nebulization Solutions
Between January and March, 2004, we quantified and identified microorganisms (bacteria, fungi) in nebulization solutions from medication cups of a total of 76 ultrasonic nebulizers in use in 10 hospitals in Yamaguchi Prefecture, Japan.
The samples were diluted 10, 10 2 , 10 3 and 10 4 times with normal saline solution. Pipettes were used to transfer 0.2 ml of the undiluted or diluted samples to trypticase soy agar or Sabouraud dextrose agar (each agar contained 0.2% Tween 80 and 0.07% soya lecithin as inactivators). Plates were streaked with a glass "hockey stick," and incubated at 30°C for 24 to 72 h (trypticase soy agar) and at 25°C for 2 to 7 d (Sabouraud dextrose agar). Colonies were counted on each plate to determine viable cells, and the organisms were identified by Gram staining, morphological examination, oxidation-fermentation test, cytochrome-oxidase test and an API system (bio Merieux sa, France).
Survey of Ultrasonic Nebulizer Disinfection Methods and Types of Nebulization Solution
An interview survey was given to nurses in charge to evaluate the frequency and method of disinfection of ultrasonic nebulizer equipment (nebulizer chamber and aerosol hose). In addition, the types of nebulization solution and the presence or absence of preservatives contained in the nebulization solutions were investigated.
The number of contaminated samples (Ն10 colony-forming units (CFU)/ml) was compared by the Wilcoxon U-test between those nebulizers disinfected once daily and those disinfected once at intervals of 2-7 d, and between the presence and absence of preservatives in nebulization solutions.
Viability of Contaminants in Various Types of Nebulization Solution
The two microorganism species used for viability tests in various types of nebulization solutions were Serratia marcescens IFO 3736, and one strain of Bulkholderia cepacia. S. marcescens were purchased from the Institute for Fermentation (Osaka, Japan). B. cepacia were isolated from a nebulization solution in use (dibekacin/betamethasone solution). 8) Stock cultures of S. marcescens and B. cepacia were maintained on trypticase soy agar at 4°C.
S. marcescens and B. cepacia were incubated on trypticase soy agar at 30°C for 48 h, harvested, and suspended with sterile physiological saline to obtain about 10 8 CFU/ml. About 10 8 CFU/ml of each strain were diluted in sterile physiological saline to obtain about 10 5 CFU/ml, and an aliquot (50 ml) of this microbial solution was inoculated into 4.95 ml of each nebulization solution and swirled for 10 s. The samples were incubated at 30°C. Plate counts were performed at 6, 24, and 48 h and at 7 d using trypticase soy agar containing 0.2% Tween 80 and 0.07% soya lecithin. This experiment was performed twice, and the mean viable count was calculated.
Measurement of pH and Water Activity of Nebulization Solution The pH of the nebulization solutions used in the viability test was measured using a pH meter F-7 type (Horiba Inc., Kyoto). Water activity (Aw) was measured using a water activity measurement system WA-40 (Gunze Inc., Tokyo).
RESULTS
Ultrasonic Nebulizer Disinfection Methods and Types of Nebulization Solution
In all 10 investigated hospitals, nebulizer chambers (medication cups) and nebulizer hoses of ultrasonic nebulizers were disinfected by immersion in We evaluated the microbial contamination of nebulization solutions in medication cups from a total of 76 ultrasonic nebulizers in use in 10 hospitals. In addition, an interview survey was given to nurses to evaluate the disinfection methods of these ultrasonic nebulizers. Of a total of 76 nebulization solution samples, 11 (14.5%) were contaminated with 10-10 2 colony-forming units (CFU)/ml and 9 (11.8%) with 10 3 -10 5 CFU/ml. The major contaminants were glucose non-fermentative bacilli such as Burkholderia cepacia, CDC gr.IV C-2, and Sphingomonas paucimobilis. Comparison of microbial contamination between the frequencies of disinfection showed a significantly lower number of contaminated samples when the cups were disinfected once daily than when disinfected once at intervals of 2-7 d ( p‫.)73000.0؍‬ In addition, comparison between the presence and absence of preservatives contained in the nebulization solution showed a significantly lower number of contaminated samples in the presence, rather than in the absence, of preservatives (p‫.)10000.0؍‬ These results show that disinfection of ultrasonic nebulizers at 24-h intervals is desirable. In particular, when nebulization solutions not containing preservatives are used, disinfection at 24-h intervals is indispensable.
0.01% (100 ppm) sodium hypochlorite for 1 h or more. Ultrasonic nebulizers were disinfected at 24-h intervals in 6 hospitals and at intervals of 2-7 d in the other 4 hospitals. Nebulization solution samples were collected from medication cups before disinfection on the day of nebulizer disinfection, but we did not investigate the interval between the previous disinfection to sample collection. The types of nebulization solution not containing preservatives included 0.9% sodium chloride for injection, distilled water for injection and Fungizone ® solution (2.5 mg/ml). The types of nebulization solution containing preservatives included Bisolvon 
Microbial Contamination of Nebulization Solutions
Of the 76 samples of nebulization solution from the medication cups of the ultrasonic nebulizers, 20 (26.3%) were contaminated with Ն10 CFU/ml. The contamination level was 10-10 2 CFU/ml in 11 samples (14.5%), 10 3 -10 5 CFU/ml in 9 (11.8%) (Fig. 1) . The major contaminants and their relative frequencies (%) were Burkholderia cepacia (35%), glucose non-fermentative bacilli that could not be identified (30%), CDC gr.IV C-2 (15%), Acinetobacter baumannii/calcoaceticus (5%), Sphingomonas paucimobilis (5%), Stenotrophomonas maltophilia (5%), and Comamonas acidovorans (5%).
Comparison between the disinfection frequencies showed a significantly lower number of contaminated samples with disinfection once daily in 6 hospitals than with disinfection at intervals of 2-7 d in the other 4 hospitals ( pϭ0.00037; Fig. 2) .
Comparison between the presence and absence of preservatives in nebulization solution showed a significantly lower number of contaminated samples in the presence of preservatives than in their absence (pϭ0.00001; Fig. 3 ). Even among samples of nebulization solution containing preservatives that were disinfected at 24-h intervals, 2 showed contamination at a level of 10 CFU/ml. Table 1 shows the preparations used in the test, the concentration of preservatives contained in each, and their pH and water activity (Aw). Though not shown in Table 1 , the pH and Aw of 1 : 2 and 1 : 10 dilutions of these preparations were measured and confirmed to be similar to those of the corresponding preparations.
Viability of Contaminants in Nebulization Solutions
Both S. marcescens and B. cepacia grew in those nebulization solutions not containing preservative (0.9% sodium chloride for injection, distilled water for injection, Fungizon ® solution) (Fig. 4) . In the nebulization solutions containing preservatives, S. marcescens did not grow in either the undiluted preparations or their dilutions, while B. cepacia did not grow in the undiluted preparations but grew in some of their dilutions (Fig. 5) .
DISCUSSION
This survey showed microbial contamination (10-10 5 CFU/ml) in 20 (26.3%) of the 76 samples of investigated nebulization solutions. There have been no previous detailed surveys that evaluated the microbial contamination of nebulization solutions, but awareness of the high susceptibility of nebulization solutions to microbial contamination may be necessary.
Microbial contamination of nebulization solutions seemed to have been caused by contaminated ultrasonic nebulizers. Indeed, comparison between the frequencies of the disinfection of ultrasonic nebulizers in this study showed a significantly lower number of contaminated samples with disinfection once daily, compared with disinfection at intervals of 2-7 d (pϭ0.00037). In the viability test, S. marcescens and B. cepacia grew rapidly in nebulization solutions not containing preservatives, showing about a 1000-fold increase in their levels after 48 h (Fig. 4) . Therefore, we recommend disinfection of ultrasonic nebulizer equipment (nebulizer chamber and nebulizer hose) at least at 24-h intervals. In all the 10 hospitals surveyed in this study, sodium hypochlorite was used for the disinfection of ultrasonic nebulizer equipment. Sodium hypochlorite is an appropriate disinfectant because of its bactericidal activity against glucose non-fermentative bacilli such as Burkholderia cepacia that are frequently detected as contaminants in aerosol solutions, and unlike alcohol, this disinfectant negligibly damages plastic materials. 13) Contamination at the 10 5 CFU/ml level was observed in 1 of the samples disinfected once daily. We speculated that the medication cup became contaminated with water in the action tank when the patient handled the cup. Indeed, examination of the water in this action tank confirmed consistency between the contaminant species in the water in the action tank and that in this sample.
On the other hand, the number of contaminated samples was significantly lower (pϭ0.00001) in nebulization solutions containing preservative (such as Bisolvon ® ϩdistilled water for injection) compared with those not containing a preservative (such as 0.9% sodium chloride for injection and distilled water for injection). Therefore, in nebulization solutions not containing a preservative, particular attention to microbial contamination is necessary. In nebulization solutions containing preservatives (Alotec ® ϩdistilled water for injection, Inolin ® ϩdistilled water for injection, Asupul ® ϩdistilled water for injection, Bisolvon ® ϩdistilled water for injection), though the preservatives contained in the products were originally diluted 1 : 2-10, the antibacterial activity of the preservatives can be expected. However, in 1 : 2-10 dilutions of some nebulization solutions containing preservatives (Meptin ® ϩdistilled water for injection, Venetlin ® ϩdistilled water for injection), the antibacterial activity of the preservatives cannot be expected (Fig. 5) . Therefore, there is a possibility that microbial contamination occurs even in nebulization solutions containing preservatives if they are diluted. In addition, the water activity of undiluted products or their 1 : 2-10 dilutions was 94.3-96.7, being appropriate for microbial proliferation. The pH of undiluted products or their 1 : 2-10 dilutions was 2.8-4.7, which is not optimal but allows for microbial proliferation. 14, 15) Therefore, attention to microbial contamination is necessary, even for nebulization solutions containing preservatives when they are diluted. 
